Biolase Diode Laser Featured in Live Surgery Broadcast At Chicago Dental Society Midwinter Meeting
SAN CLEMENTE, Calif., Feb. 29 /PRNewswire/ -- Biolase Technology, Inc. (Nasdaq: BLTI - news), today announced that its TwiLite(TM) diode laser was demonstrated during a live closed-circuit TV broadcast from Northwestern University Dental School to an auditorium of dentists at the Chicago Dental Society's 135th Midwinter Meeting last week. The demonstration, an aesthetic tissue recontouring surgery, was performed by Peter Rinaldi, D.M.D., a renowned cosmetic dentist.
Dr. Rinaldi's presentation, ``Veneers: A Demonstration in Preparation, Design and Cementation,'' focused on the necessary fundamentals for properly preparing and seating cosmetic veneers. Following the surgery, Dr. Rinaldi commented, ``The TwiLite worked very well and the results were fantastic. I was able to recontour the tissue without any bleeding. The advantages of using diode lasers are that the margins are very predictable, there is almost no post-operative discomfort and the tissue heals very well compared to other technologies. The diode laser is a must for any dentist performing cosmetic procedures.''
Dr. Rinaldi is a renowned cosmetic dentist in private practice with Dr. Larry Rosenthal in New York City. He is the clinical director for some of the leading aesthetic hands-on post graduate courses, Aesthetic Advantage, which are presented at Baylor College of Dentistry, New York University, Palm Beach Community College and the University of Kentucky College of Dentistry. Dr. Rinaldi has also published numerous articles on cosmetic dentistry and lectures extensively.
The TwiLite diode laser, which received clearance from the Food and Drug Administration in late September 1999, is a revolutionary lightweight laser ideally suited for a range of soft tissue procedures. It is equipped with robust, state-of-the-art features favored by dentists, including a ``power on demand'' foot switch that allows users to quickly increase or decrease power levels while continuing treatment.
Dental diode laser sales in the U.S. are projected to increase 300 percent in 2000 over 1999, and an additional 55 percent in 2001, according to a recent independent study. The study, ``U.S. Market for Dental Products 2000,'' prepared by the Millennium Research Group in Toronto, Canada, also projects that dental diode laser sales will continue to increase more than 20 percent per year through 2004.
Jeffrey W. Jones, Biolase president and CEO, commented, ``Cosmetic procedures represent a rapidly growing business for dentists, and one of the most requested procedures is veneers for the anterior teeth. According to the leading cosmetic dentists, a diode laser is clearly the most effective, and a necessary, tool for tissue recontouring and 'smile design.'''
Jones added, ``In just a short time, Biolase has become the diode laser of choice among prominent and influential dentists, and that was the reason our laser was selected for this important demonstration. Attendance at courses for cosmetic dentistry such as these is growing, fueled by dentists' desire to provide their patients with additional services, increase revenue and improve the profitability of their practices. Biolase has already been selected by several of the top courses and is pursuing opportunities with all of the other most prominent courses and their key dentists. Having our laser featured at these courses and used by their dentists are two of the most effective ways to market and sell our feature-rich TwiLite.''
Biolase Technology, Inc. (www.biolase.com), manufactures and markets advanced dental, cosmetic, aesthetic and surgical products, including Hydrokinetic(TM) surgical cutting systems and other advanced laser and non-laser based products for the professional and home consumer market. The company's products incorporate patented and patent-pending technologies in the pursuit of painless surgery.
The matters discussed in this news release include forward-looking statements which are subject to various risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated in such forward-looking statements. Such risks, uncertainties and other factors include, but are not limited to, the effect of actions of third parties, including governmental officials, the timely development and acceptance of new products, the impact of competitive products and pricing, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission, including the reports on Forms 10-K and 10-Q. These forward-looking statements represent the Company's judgment as of the date of this release. The Company disclaims, however, any intent or obligation to update these forward-looking statements.